MADDEN SECURITIES Corp lessened its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 74.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 20,550 shares of the real estate investment trust's stock after selling 61,145 shares during the period. MADDEN SECURITIES Corp's holdings in Omega Healthcare Investors were worth $753,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently modified their holdings of the company. GAMMA Investing LLC boosted its holdings in Omega Healthcare Investors by 4,248.2% in the 1st quarter. GAMMA Investing LLC now owns 174,102 shares of the real estate investment trust's stock valued at $6,630,000 after purchasing an additional 170,098 shares during the last quarter. NBC Securities Inc. acquired a new stake in shares of Omega Healthcare Investors during the 1st quarter worth approximately $29,000. UMB Bank n.a. raised its position in shares of Omega Healthcare Investors by 94.9% during the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after buying an additional 1,059 shares during the period. Park Avenue Securities LLC lifted its holdings in Omega Healthcare Investors by 18.2% in the first quarter. Park Avenue Securities LLC now owns 18,534 shares of the real estate investment trust's stock valued at $706,000 after acquiring an additional 2,854 shares during the last quarter. Finally, Capital Investment Advisors LLC purchased a new position in Omega Healthcare Investors in the first quarter worth approximately $326,000. Hedge funds and other institutional investors own 65.25% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on OHI shares. Mizuho lifted their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a research report on Thursday, September 11th. Truist Financial raised their price objective on Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a "hold" rating in a research report on Wednesday, September 3rd. Cantor Fitzgerald assumed coverage on shares of Omega Healthcare Investors in a report on Wednesday, October 1st. They issued an "overweight" rating and a $50.00 price objective on the stock. Raymond James Financial reaffirmed an "outperform" rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Finally, Weiss Ratings reaffirmed a "buy (b)" rating on shares of Omega Healthcare Investors in a research note on Saturday, September 27th. Seven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $44.44.
Check Out Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Price Performance
OHI opened at $40.90 on Tuesday. The stock's 50-day moving average price is $41.48 and its 200 day moving average price is $38.74. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm has a market cap of $12.07 billion, a price-to-earnings ratio of 25.25, a PEG ratio of 2.15 and a beta of 0.70.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. The company had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business's revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, sell-side analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.
Omega Healthcare Investors Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.6%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is presently 165.43%.
Insider Transactions at Omega Healthcare Investors
In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the transaction, the director owned 18,654 shares of the company's stock, valued at $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 1.50% of the stock is currently owned by company insiders.
Omega Healthcare Investors Company Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Recommended Stories
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.